Illumina (ILMN) Restructuring Costs (2012 - 2022)

Illumina (ILMN) posted quarterly Restructuring Costs of $609.0 million for Q3 2022, up 7712.5% on a QoQ basis from -$8.0 million in Q3 2017.

Illumina (ILMN) Restructuring Costs (2012 - 2022) Analysis & Trends

Illumina has reported Restructuring Costs for 7 years, with the latest figure at $609.0 million in Q3 2022.

Restructuring Costs for Q3 2022 came in at $609.0 million, changed N/A year-over-year; the trailing twelve-month figure through Jul 2022 was $609.0 million (changed N/A YoY), and the FY2017 annual result was -$9.0 million, down 147.37% from the prior year.
Restructuring Costs improved to $609.0 million in Q3 2022, from -$8.0 million in the prior quarter.
Over five years, Restructuring Costs peaked at $609.0 million in Q3 2022 and troughed at $609.0 million in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	213.68 Bn	209.62 Bn	8.34 Bn
2	Danaher	140.36 Bn	136.01 Bn	3.61 Bn
3	Idexx Laboratories	46.24 Bn	46.05 Bn	779.09 Mn
4	Agilent Technologies	39.65 Bn	37.84 Bn	990.00 Mn
5	Iqvia Holdings	39.23 Bn	37.15 Bn	1.44 Bn
6	Natera	38.88 Bn	37.78 Bn	696.04 Mn
7	Illumina	30.04 Bn	28.87 Bn	770.00 Mn
8	Mettler Toledo International	28.62 Bn	28.57 Bn	650.22 Mn
9	Quest Diagnostics	26.22 Bn	25.59 Bn	1.03 Bn
10	Labcorp Holdings	25.83 Bn	24.85 Bn	1.01 Bn

Download Data